HUMANISIERTE UND DEIMMUNISIERTE ANTIKÖRPER

European patent · EP3521308 · In force

Register entry

Publication number
EP3521308
Application number
EP18154427
Kind
European patent with effect for Switzerland and Liechtenstein
Status
In force
Specification
Granted
Filed
Jan 31, 2018
Published
Aug 7, 2019
Granted
Mar 13, 2024
Protection ends at the latest
Jan 30, 2038
Next annual fee due
Jan 31, 2027
IPC classes
C07K 16/18 (2006.01)
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Feb 1, 2026

    Change

    Published in Swissreg on 01.02.2026

  2. Feb 1, 2025

    Change

    Published in Swissreg on 01.02.2025

  3. Jan 22, 2025

    Change

    Published in Swissreg on 22.01.2025

  4. May 30, 2024

    Agent entered

    Representative
    Schmauder & Partner AG, Patent- und Markenanwälte VSP, Zwängiweg 7, 8038 Zürich

    Published in Swissreg on 30.05.2024

  5. Mar 13, 2024

    Granted

    Published in Swissreg on 13.03.2024

Parties

Holder

Vivoryon Therapeutics N.V.

Weinbergweg 22, 06120 Halle, DE

Agent

Schmauder & Partner AG

Schmauder & Partner AG Patent- und Markenanwälte VSP

Zwängiweg 7, 8038 Zürich

Inventor

KLEINSCHMIDT, Martin

06114 Halle (Saale), DE

GILLIES, Stephen

Carlisle, MA 01741, US

HETTMANN, Thore

14513 Teltow, DE

SCHILLING, Stefan

06130 Halle (Saale), DE

RAHFELD, Jens-Ulrich

06317 Gemeinde Seegebiet Mansfelder Land, DE

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.